Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2019/01/017211
CTRI/2019/01/017211
Not yet recruiting
未知

A study to evaluate ocular changes in patients undergoing spine surgery in prone position

Department of Anaesthesiology0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: W19- Unspecified fall

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: W19- Unspecified fall
Sponsor
Department of Anaesthesiology
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Department of Anaesthesiology

Eligibility Criteria

Inclusion Criteria

  • •Adult patient aged between 18\-60 years of either sex belonging to ASA 1 or 11 Scheduled for elective spine surgery in prone position

Exclusion Criteria

  • •patients with history of hypertension, eye infection/ injury, previous eye surgery, DM, Difficult airway, Uveitis, Allergy to local anesthetics.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Visual disturbances of patients following operatioHealth Condition 1: O- Medical and Surgical
CTRI/2023/03/050562GCS medical college and hospital
Terminated
Not Applicable
Changes in ocular mucin expression due to contact lens wear
ACTRN12609000447257Institute for Eye Research30
Active, not recruiting
Not Applicable
A phase IIIb study on the changes in ocular signs, symptoms and conjunctival inflammatory markers in patients with ocular hypertension or open-angle glaucoma switched from preserved latanoprost 0.005% eye drops to preservative free tafluprost 0.0015% eye drops.
EUCTR2007-004872-37-DESanten Oy150
Active, not recruiting
Not Applicable
A phase IIIb study on the changes in ocular signs, symptoms and conjunctival inflammatory markers in patients with ocular hypertension or open-angle glaucoma switched from preserved latanoprost 0.005% eye drops to preservative free tafluprost 0.0015% eye drops.
EUCTR2007-004872-37-SESanten Oy150
Active, not recruiting
Not Applicable
A phase IIIb study on the changes in ocular signs, symptoms and conjunctival inflammatory markers in patients with ocular hypertension or primary open-angle glaucoma switched from preserved latanoprost 0.005% eye drops to preservative free tafluprost 0.0015% eye drops.Ocular hypertension or open angle glaucoma patients are enrolled into this trial.
EUCTR2007-004872-37-FISanten Oy150